细胞株和菌株、胎牛血清、生化试剂、ELISA试剂盒、抗体和抗原、细胞因子、技术服务、实验耗材和消耗品、仪器设备。

产品与服务:

产品中心
  • 产品名称:Bioporto | (ABS 012-35B-005)货号查询 Exendin-4

  • 产品型号:50µl
  • 产品厂商:BioPorto Diagnostics A/S
  • 产品价格:0
  • 折扣价格:0
  • 产品文档:
你添加了1件商品 查看购物车
简单介绍:
Bioporto | Bioporto | (ABS 012-35B-005)货号查询 Exendin-4 Bioporto 400-968-7988 Exendin-4 请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 012-35B-005)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html
详情介绍:

Bioporto  400-968-7988

Bioporto | (ABS 012-35B-005)货号查询 Exendin-4

Bioporto 400-968-7988

请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 012-35B-005)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html


Ready-to-use NGAL Test? for BN Systems has been launched by Siemens

NOW AVAILABLE: THE NGAL TEST FOR SIEMENS BN SYSTEMS

May 2017

Renal biomarker market to reach US$ 1,770 Mn by 2026

NEW MARKET REPORT FROM FUTURE MARKET INSIGHTS

December 2016

New antibodies in the area of infectious disease

NEW ANTIBODIES LAUNCHED

April 2016

New antibodies in the area of peptide hormones and infectious diseases

LAUNCH OF NEW ANTIBODIES

December 2015


Bioporto | (ABS 012-35B-005)货号查询
Bioporto 400-968-7988
请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 012-35B-005)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html


CSA-NGAL SCORE

SCIENTIFIC ADVISORY BOARD

Cardiac surgery-associated acute kidney injury (CSA-AKI):

Discussion Cardiac surgery-associated NGAL (CSA-NGAL) score

BioPorto is proud to announce that the paper "The cardiac surgery-associated NGAL score: a potential tool to monitor acute tubular damage" authored by our esteemed Scientific Advisory Board chaired by Prof. Dr. med Jean-Louis Vincent have been accepted in The Journal of Thoracic and Cardiovascular Surgery.
 
 Download paper here.

BioPorto Scientific Advisory Board members are

  • Prof. Dr. med Jean-Louis Vincent, Erasme, Belgium. (Chair)
  • Assoc. Prof. Dr. med Andrew Lewington, St. James’s University Hospital, Leeds, UK. 
  • Director Dr. med Claudio Ronco, San Bortolo Hospital, Vicenza, Italy
  • Prof. Dr. med Laurent Jacob, Saint-Louis Hospital, Paris, France
  • Prof. Dr. med Michael Haase, Otto-von Guericke University, Magdeburg, Germany
  • Dr. med, PhD, Hilde RH de Geus, Eramus University Medical Center Rotterdam, NL

Important recognition of NGAL as a potential tool to monitor acute tubular damage

While a large number of scientific articles documenting NGAL’s use as a marker for the detection of acute kidney injury have been published, the Advisory Board’s white paper is the first article suggesting guidelines based on reported clinical use of NGAL for the intervention and patient management both before and after the operation based on measurements of NGAL.

For the first time, the article equips the clinical staff at the cardiac intensive care unit with a decision algorithm for the practical application of NGAL. BioPorto expects that the article will be given weight in the decision-making processes that lead to the inclusion of NGAL tests in official clinical guidelines, which in several countries are determined at a national level.

Peter M?rch Eriksen, CEO of BioPorto, said: "The Journal of Thoracic and Cardiovascular Surgery publishing the Advisory Board’s white paper is an important recognition of NGAL and a strategic milestone for BioPorto. I am convinced that the article with the suggested guidelines will open doors for NGAL-based tests worldwide and contribute to faster and improved renal injury diagnostics for the benefit of patients and clinicians."

About BioPorto Diagnostics A/S

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the NASDAQ OMX: BIOPOR Copenhagen stock exchange.


Bioporto | (ABS 012-35B-005)货号查询
Bioporto 400-968-7988
请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 012-35B-005)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html

PRODUCTS

BioPorto Diagnostics have through dedicated research and product development been able to offer a strong range of thoroughly validated antibodies, which can be used for pharmaceutical as well as scientific research. We offer several antibodies with high specificity within medical specialties such as Obesity, Diabetes and Primary Immune Deficiency. For research use only.

Once our antibodies have been validated and introduced to the scientific research community we further develop key antibodies into highly specific immunoassays and our dedicated approach to identifying and targeting biomarkers addressing unmet clinical needs in the management of acute conditions has enabled us to offer a biomarker - The NGAL Test - for early risk assessment of acute kidney injury (AKI) in several medical and surgical specialties. The NGAL Test is not available in the USA for in vitro diagnostic use.

Bulk Antibodies

BioPorto Product Catalogue 2014     Learn more about your opportunities - click here.

 

NGAL
BUY ONLINE
NGAL
AS EARLY AKI DETECTION COUNTS

The NGAL Test – first diagnostic acute kidney injury biomarker which can be measured in both human urine and plasma. NGAL measurements are useful in the diagnosis of acute kidney injury which may lead to acute renal failure.

The NGAL Test is not available in the USA for in vitro diagnostic use.

We have also launched a unique range of NGAL human an animal antibodies and ELISA kits for research on nephrotoxity.

Antibodies
BUY ONLINE
ANTIBODIES AND IMMUNOASSAYS

Enter our world of high quality monoclonal antibodies and immunoassays. We offer highly specific antibodies for pharmaceutical research and in vitro diagnostic test. Antibodies from BioPorto Diagnostics are in several cases highly cited under the Antibodyshop brand.

We have unique antibodies in areas such as diabetes and obesity, allergy and immune deficiency.

Lateral flow
BUY ONLINE
LATERAL FLOW
NEW GENERIC STRIP

With the new gRAd OneDetection Kit YOU have all needed to speed up your research and develop your own custom lateral flow assays.

Developing your own customized lateral flow assay has now become easier and faster with the gRAD OneDetection Kit. Using BioPorto Diagnostics' gRAD One Detection Kit, you will be able to develop a new test in just a couple of weeks.